These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35463194)

  • 41. Phenotyping of hypertensive heart disease and hypertrophic cardiomyopathy using personalized 3D modelling and cardiac cine MRI.
    Chuah SH; Md Sari NA; Chew BT; Tan LK; Chiam YK; Chan BT; Lim E; Abdul Aziz YF; Liew YM
    Phys Med; 2020 Oct; 78():137-149. PubMed ID: 33007738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy.
    Smole T; Žunkovič B; Pičulin M; Kokalj E; Robnik-Šikonja M; Kukar M; Fotiadis DI; Pezoulas VC; Tachos NS; Barlocco F; Mazzarotto F; Popović D; Maier L; Velicki L; MacGowan GA; Olivotto I; Filipović N; Jakovljević DG; Bosnić Z
    Comput Biol Med; 2021 Aug; 135():104648. PubMed ID: 34280775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study.
    Greulich S; Seitz A; Herter D; Günther F; Probst S; Bekeredjian R; Gawaz M; Sechtem U; Mahrholdt H
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):732-741. PubMed ID: 33458753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of a Center of Excellence in Confirming or Excluding a Diagnosis of Hypertrophic Cardiomyopathy.
    Farrar E; Bilchick KC; Gadi SR; Hosadurg N; Kramer CM; Patel AR; Mcclean K; Thomas M; Ayers MP
    Am J Cardiol; 2023 Dec; 208():83-91. PubMed ID: 37820551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Abdelfattah OM; Martinez M; Sayed A; ElRefaei M; Abushouk AI; Hassan A; Masri A; Winters SL; Kapadia SR; Maron BJ; Rowin E; Maron MS
    JACC Clin Electrophysiol; 2022 Nov; 8(11):1417-1427. PubMed ID: 36424010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study.
    Tian D; Zhang J; He Y; Xiong Z; Zhao M; Hu S; Song Q; Li Z
    BMC Cardiovasc Disord; 2023 Jan; 23(1):42. PubMed ID: 36690952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification.
    Alajmi F; Kang M; Dundas J; Haenel A; Parker J; Blanke P; Coghlan F; Khoo JK; Bin Zaid AA; Singh A; Heydari B; Yeung D; Roston TM; Ong K; Leipsic J; Laksman Z
    Life (Basel); 2024 Jan; 14(2):. PubMed ID: 38398708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automatic machine learning based on native T1 mapping can identify myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Peng WL; Zhang TJ; Shi K; Li HX; Li Y; He S; Li C; Xia D; Xia CC; Li ZL
    Eur Radiol; 2022 Feb; 32(2):1044-1053. PubMed ID: 34477909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy.
    Gu ZY; Qian YF; Chen BH; Wu CW; Zhao L; Xue S; Zhao L; Wu LM; Wang YY
    Insights Imaging; 2023 Aug; 14(1):138. PubMed ID: 37603140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management.
    Shafqat A; Shaik A; Koritala S; Mushtaq A; Sabbah BN; Nahid Elshaer A; Baqal O
    Front Cardiovasc Med; 2023; 10():1277041. PubMed ID: 38250029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.
    Noureldin RA; Liu S; Nacif MS; Judge DP; Halushka MK; Abraham TP; Ho C; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):17. PubMed ID: 22348519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural Language Processing for the Ascertainment and Phenotyping of Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy on Echocardiogram Reports.
    Berman AN; Ginder C; Sporn ZA; Tanguturi V; Hidrue MK; Shirkey LB; Zhao Y; Blankstein R; Turchin A; Wasfy JH
    Am J Cardiol; 2023 Nov; 206():247-253. PubMed ID: 37714095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
    He D; Ye M; Zhang L; Jiang B
    Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance.
    Huurman R; van der Velde N; Schinkel AFL; Hassing HC; Budde RPJ; van Slegtenhorst MA; Verhagen JMA; Hirsch A; Michels M
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1144-1154. PubMed ID: 35670722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baseline and Longitudinal Imaging of Hypertrophic Cardiomyopathy in the Era of Emerging Therapeutics.
    Altibi A; Alani A; Zhao Y; Masri A
    Curr Cardiol Rep; 2023 Jun; 25(6):583-595. PubMed ID: 37103749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of cardiac magnetic resonance in hypertrophic cardiomyopathy over the past 10 years [2013-2023]: a CiteSpace-based bibliometric analysis.
    Hu M; Shen Y; Song Y; Li S; Yang P; Kan A; Fang Q; Peng Y; Ren H; Zhang Y; Gong L
    Quant Imaging Med Surg; 2024 Jan; 14(1):566-578. PubMed ID: 38223124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
    Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study.
    Schulze Lammers S; Lawrenz T; Lawin D; Hoyer A; Stellbrink C; Albrecht UV
    JMIR Res Protoc; 2023 Dec; 12():e52035. PubMed ID: 38157231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.